Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) FCF Margin (2016 - 2025)

Historic FCF Margin for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to 172.49%.

  • Kyntra Bio's FCF Margin rose 67039300.0% to 172.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 113.47%, marking a year-over-year decrease of 641000.0%. This contributed to the annual value of 1920.35% for FY2024, which is 12418900.0% down from last year.
  • Kyntra Bio's FCF Margin amounted to 172.49% in Q3 2025, which was up 67039300.0% from 939.84% recorded in Q2 2025.
  • Kyntra Bio's 5-year FCF Margin high stood at 939.84% for Q2 2025, and its period low was 9970.75% during Q2 2024.
  • Moreover, its 5-year median value for FCF Margin was 172.49% (2025), whereas its average is 1458.56%.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -91960000bps in 2024, then soared by 109105900bps in 2025.
  • Kyntra Bio's FCF Margin (Quarter) stood at 340.66% in 2021, then surged by 55bps to 153.77% in 2022, then surged by 116bps to 25.16% in 2023, then surged by 531bps to 158.7% in 2024, then tumbled by -209bps to 172.49% in 2025.
  • Its FCF Margin was 172.49% in Q3 2025, compared to 939.84% in Q2 2025 and 150.17% in Q1 2025.